Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 52

1.

Cyclin-Like Proteins Tip Regenerative Balance in the Liver to Favour Cancer Formation.

Fifield BA, Talia J, Stoyanovich C, Elliott MJ, Bakht MK, Basilious A, Samsoondar JP, Curtis M, Stringer KF, Porter LA.

Carcinogenesis. 2019 Oct 2. pii: bgz164. doi: 10.1093/carcin/bgz164. [Epub ahead of print]

PMID:
31574533
2.

Neuro- and hepatic toxicological profile of (S)-2,4-diaminobutanoic acid in embryonic, adolescent and adult zebrafish.

Ferraiuolo RM, Meister D, Leckie D, Dashti M, Franke J, Porter LA, Trant JF.

J Appl Toxicol. 2019 Aug 6. doi: 10.1002/jat.3840. [Epub ahead of print]

PMID:
31389051
3.

Transcriptomics Signature from Next-Generation Sequencing Data Reveals New Transcriptomic Biomarkers Related to Prostate Cancer.

Alkhateeb A, Rezaeian I, Singireddy S, Cavallo-Medved D, Porter LA, Rueda L.

Cancer Inform. 2019 Mar 13;18:1176935119835522. doi: 10.1177/1176935119835522. eCollection 2019.

4.

The Tuberin and Cyclin B1 complex functions as a novel G2/M sensor of serum conditions and Akt signaling.

Fidalgo da Silva E, Botsford S, Dare-Shih J, Hanna MA, Porter LA.

PLoS One. 2019 Jan 10;14(1):e0210612. doi: 10.1371/journal.pone.0210612. eCollection 2019.

5.

Neuroendocrine differentiation of prostate cancer leads to PSMA suppression.

Bakht MK, Derecichei I, Li Y, Ferraiuolo RM, Dunning M, Oh SW, Hussein A, Youn H, Stringer KF, Jeong CW, Cheon GJ, Kwak C, Kang KW, Lamb AD, Wang Y, Dong X, Porter LA.

Endocr Relat Cancer. 2018 Nov 23;26(2):131-146. doi: 10.1530/ERC-18-0226.

PMID:
30400059
6.

Cell Cycle Dynamics in Glioma Cancer Stem Cells.

Qemo I, Porter LA.

Methods Mol Biol. 2019;1869:117-126. doi: 10.1007/978-1-4939-8805-1_11.

PMID:
30324519
7.

Bacteriophages.

Kasman LM, Porter LD.

StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2019 Jan-.
2019 Aug 12.

8.

Examining Practice and Learning Effects With Serial Administration of the Clinical Reaction Time Test in Healthy Young Athletes.

Nguyen CN, Clements RN, Porter LA, Clements NE, Gray MD, Killian DJ, Baker RT.

J Sport Rehabil. 2019 Aug 1;28(6):558-563. doi: 10.1123/jsr.2017-0340.

PMID:
29584536
9.

Structural basis of divergent cyclin-dependent kinase activation by Spy1/RINGO proteins.

McGrath DA, Fifield BA, Marceau AH, Tripathi S, Porter LA, Rubin SM.

EMBO J. 2017 Aug 1;36(15):2251-2262. doi: 10.15252/embj.201796905. Epub 2017 Jun 30.

10.

The cyclin-like protein, SPY1, regulates the ERα and ERK1/2 pathways promoting tamoxifen resistance.

Ferraiuolo RM, Tubman J, Sinha I, Hamm C, Porter LA.

Oncotarget. 2017 Apr 4;8(14):23337-23352. doi: 10.18632/oncotarget.15578.

11.

The Potential Roles of Radionanomedicine and Radioexosomics in Prostate Cancer Research and Treatment.

Bakht MK, Oh SW, Hwang DW, Lee YS, Youn H, Porter LA, Cheon GJ, Kwak C, Lee DS, Kang KW.

Curr Pharm Des. 2017;23(20):2976-2990. doi: 10.2174/1381612823666170216122412. Review.

PMID:
28215159
12.

Activated thrombin-activatable fibrinolysis inhibitor attenuates the angiogenic potential of endothelial cells: potential relevance to the breast tumour microenvironment.

Bazzi ZA, Balun J, Cavallo-Medved D, Porter LA, Boffa MB.

Clin Exp Metastasis. 2017 Feb;34(2):155-169. doi: 10.1007/s10585-017-9837-y. Epub 2017 Jan 25.

PMID:
28124276
13.

Activated thrombin-activatable fibrinolysis inhibitor (TAFIa) attenuates breast cancer cell metastatic behaviors through inhibition of plasminogen activation and extracellular proteolysis.

Bazzi ZA, Lanoue D, El-Youssef M, Romagnuolo R, Tubman J, Cavallo-Medved D, Porter LA, Boffa MB.

BMC Cancer. 2016 May 24;16:328. doi: 10.1186/s12885-016-2359-1.

14.

A novel model used to detect differential splice junctions as biomarkers in prostate cancer from RNA-Seq data.

Rezaeian I, Tavakoli A, Cavallo-Medved D, Porter LA, Rueda L.

J Biomed Inform. 2016 Apr;60:422-30. doi: 10.1016/j.jbi.2016.03.010. Epub 2016 Mar 15.

15.

Direct interactions with both p27 and Cdk2 regulate Spy1-mediated proliferation in vivo and in vitro.

Al Sorkhy M, Fifield BA, Myers D, Porter LA.

Cell Cycle. 2016;15(1):128-36. doi: 10.1080/15384101.2015.1121327.

16.

Sodium salicylate reduces the level of GABAB receptors in the rat's inferior colliculus.

Butt S, Ashraf F, Porter LA, Zhang H.

Neuroscience. 2016 Mar 1;316:41-52. doi: 10.1016/j.neuroscience.2015.12.021. Epub 2015 Dec 17.

PMID:
26705739
17.

Paclitaxel-induced transcriptional regulation of Fas signaling pathway is antagonized by dexamethasone.

Crozier M, Porter LA.

Breast Cancer Res Treat. 2015 Nov;154(1):33-44.

PMID:
26463651
18.
19.

Atypical cell cycle control over neural cell fate.

Lubanska D, Porter LA.

Cell Cycle. 2014;13(19):2987. doi: 10.4161/15384101.2014.962849. No abstract available.

20.

Derivation of a novel G2 reporter system.

Fidalgo da Silva E, Botsford S, Porter LA.

Cytotechnology. 2016 Jan;68(1):19-24. doi: 10.1007/s10616-014-9757-5. Epub 2014 Jul 1.

21.

The cyclin-like protein Spy1 regulates growth and division characteristics of the CD133+ population in human glioma.

Lubanska D, Market-Velker BA, deCarvalho AC, Mikkelsen T, Fidalgo da Silva E, Porter LA.

Cancer Cell. 2014 Jan 13;25(1):64-76. doi: 10.1016/j.ccr.2013.12.006.

22.

The cyclin-like protein Spy1/RINGO promotes mammary transformation and is elevated in human breast cancer.

Al Sorkhy M, Ferraiuolo RM, Jalili E, Malysa A, Fratiloiu AR, Sloane BF, Porter LA.

BMC Cancer. 2012 Jan 26;12:45. doi: 10.1186/1471-2407-12-45.

23.

The tumor suppressor tuberin regulates mitotic onset through the cellular localization of cyclin B1.

Fidalgo da Silva E, Ansari SB, Maimaiti J, Barnes EA, Kong-Beltran M, Donoghue DJ, Porter LA.

Cell Cycle. 2011 Sep 15;10(18):3129-39. Epub 2011 Sep 15.

PMID:
21900748
24.

The level and distribution of the GABA(B)R2 receptor subunit in the rat's central auditory system.

Jamal L, Zhang H, Finlayson PG, Porter LA, Zhang H.

Neuroscience. 2011 May 5;181:243-56. doi: 10.1016/j.neuroscience.2011.02.050. Epub 2011 Mar 1.

PMID:
21371537
25.

Influence of neutrophil defects on Burkholderia cepacia complex pathogenesis.

Porter LA, Goldberg JB.

Front Cell Infect Microbiol. 2011 Nov 18;1:9. doi: 10.3389/fcimb.2011.00009. eCollection 2011. Review.

26.

Relating the physical properties of Pseudomonas aeruginosa lipopolysaccharides to virulence by atomic force microscopy.

Ivanov IE, Kintz EN, Porter LA, Goldberg JB, Burnham NA, Camesano TA.

J Bacteriol. 2011 Mar;193(5):1259-66. doi: 10.1128/JB.01308-10. Epub 2010 Dec 10.

27.

Broad-host-range plasmids for red fluorescent protein labeling of gram-negative bacteria for use in the zebrafish model system.

Singer JT, Phennicie RT, Sullivan MJ, Porter LA, Shaffer VJ, Kim CH.

Appl Environ Microbiol. 2010 Jun;76(11):3467-74. doi: 10.1128/AEM.01679-09. Epub 2010 Apr 2.

28.

The cyclin-dependent kinase activator, Spy1A, is targeted for degradation by the ubiquitin ligase NEDD4.

Al Sorkhy M, Craig R, Market B, Ard R, Porter LA.

J Biol Chem. 2009 Jan 30;284(5):2617-27. doi: 10.1074/jbc.M804847200. Epub 2008 Dec 3.

29.

The Spy1/RINGO family represents a novel mechanism regulating mammary growth and tumorigenesis.

Golipour A, Myers D, Seagroves T, Murphy D, Evan GI, Donoghue DJ, Moorehead RA, Porter LA.

Cancer Res. 2008 May 15;68(10):3591-600. doi: 10.1158/0008-5472.CAN-07-6453.

30.

Spy1 enhances phosphorylation and degradation of the cell cycle inhibitor p27.

McAndrew CW, Gastwirt RF, Meyer AN, Porter LA, Donoghue DJ.

Cell Cycle. 2007 Aug 1;6(15):1937-45. Epub 2007 May 30.

PMID:
17671428
31.

Synthesis and patterning of gold nanostructures on InP and GaAs via galvanic displacement.

Hormozi Nezhad MR, Aizawa M, Porter LA Jr, Ribbe AE, Buriak JM.

Small. 2005 Nov;1(11):1076-81. No abstract available.

PMID:
17193399
32.

Cyclin B1 and CDK1: nuclear localization and upstream regulators.

Porter LA, Donoghue DJ.

Prog Cell Cycle Res. 2003;5:335-47. Review.

PMID:
14593728
33.

Spy1 interacts with p27Kip1 to allow G1/S progression.

Porter LA, Kong-Beltran M, Donoghue DJ.

Mol Biol Cell. 2003 Sep;14(9):3664-74. Epub 2003 Jul 11.

34.

Human Spy1 promotes survival of mammalian cells following DNA damage.

Barnes EA, Porter LA, Lenormand JL, Dellinger RW, Donoghue DJ.

Cancer Res. 2003 Jul 1;63(13):3701-7.

35.

Nuclear localization of cyclin B1 regulates DNA damage-induced apoptosis.

Porter LA, Cukier IH, Lee JM.

Blood. 2003 Mar 1;101(5):1928-33. Epub 2002 Nov 7.

PMID:
12424202
36.

Protein elongation factor EEF1A2 is a putative oncogene in ovarian cancer.

Anand N, Murthy S, Amann G, Wernick M, Porter LA, Cukier IH, Collins C, Gray JW, Diebold J, Demetrick DJ, Lee JM.

Nat Genet. 2002 Jul;31(3):301-5. Epub 2002 Jun 10.

PMID:
12053177
37.

Human Speedy: a novel cell cycle regulator that enhances proliferation through activation of Cdk2.

Porter LA, Dellinger RW, Tynan JA, Barnes EA, Kong M, Lenormand JL, Donoghue DJ.

J Cell Biol. 2002 Apr 29;157(3):357-66. Epub 2002 Apr 29.

38.

alpha-, beta-, and gamma-Tubulin polymerization in response to DNA damage.

Porter LA, Lee JM.

Exp Cell Res. 2001 Nov 1;270(2):151-8.

PMID:
11640879
39.

Abundance of cyclin B1 regulates gamma-radiation-induced apoptosis.

Porter LA, Singh G, Lee JM.

Blood. 2000 Apr 15;95(8):2645-50.

PMID:
10753846
40.

Gold and Silver Nanoparticles Functionalized by the Adsorption of Dialkyl Disulfides.

Porter LA Jr, Ji D, Westcott SL, Graupe M, Czernuszewicz RS, Halas NJ, Lee TR.

Langmuir. 1998 Dec 22;14(26):7378-7386. doi: 10.1021/la980870i.

PMID:
31416111
41.

Drug profiles: maximizing therapeutic effectiveness.

Porter LA, Dunbar SB.

J Cardiovasc Nurs. 1995 Oct;10(1):64-72. Review.

PMID:
8537832
42.

Breast cancer in NSW women: a shift in tumour size.

Kricker A, Høyer AP, McCredie M, Porter LA.

Med J Aust. 1995 Jul 17;163(2):79-81.

PMID:
7616902
43.

Procedural distress in critical care settings.

Porter LA.

Crit Care Nurs Clin North Am. 1995 Jun;7(2):307-14. Review.

PMID:
7619373
44.

The applicability of sequential analysis to nursing research.

Brown JK, Porter LA, Knapp TR.

Nurs Res. 1993 Sep-Oct;42(5):280-2. No abstract available.

PMID:
8415041
45.

Social support and long-term recovery from coronary artery surgery: effects on patients and spouses.

King KB, Reis HT, Porter LA, Norsen LH.

Health Psychol. 1993 Jan;12(1):56-63.

PMID:
8462500
46.

Patient perceptions of quality of life after coronary artery surgery: was it worth it?

King KB, Porter LA, Norsen LH, Reis HT.

Res Nurs Health. 1992 Oct;15(5):327-34.

PMID:
1529116
47.
49.

Biological potency of organic selenium compounds. IV. Straight-chain dialkylmono- and diselenides.

Schwarz K, Porter LA, Fredga A.

Bioinorg Chem. 1974 Jan;3(2):145-52. No abstract available.

PMID:
4441549
50.

Some regularities in the structure-function relationship of organoselenium compounds effective against dietary liver necrosis.

Schwarz K, Porter LA, Fredga A.

Ann N Y Acad Sci. 1972 Apr 17;192:200-14. No abstract available.

PMID:
4503564

Supplemental Content

Loading ...
Support Center